Skip to main content

Invesco Ltd.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 914208 Atlanta, GA

Position in HALO

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$259,327,483
+$13,812,847 QoQ
Shares Held
4,012,494
+10.0% QoQ
Ownership
3.38%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 97.69467568051192.ToString("F0")% None 2.305324319488079.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Invesco Ltd. holds $10,689,611,381 across 259 Biotechnology names. HALO ranks #8 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 HALO
Halozyme Therapeutics, Inc.
This page
4,012,494 $259,327,483

All Filings in HALO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $259,327,483 4,012,494
2025-12-31 $245,514,636 3,648,063
2025-09-30 $238,044,765 3,245,770
2025-06-30 $180,295,541 3,465,889
2025-03-31 $248,495,088 3,894,297
2024-12-31 $113,521,113 2,374,422
2024-09-30 $109,423,413 1,911,660
2024-06-30 $116,445,391 2,223,938
2024-03-31 $84,956,515 2,088,410
2023-12-31 $75,052,230 2,030,634
2023-09-30 $77,050,237 2,017,022
2023-06-30 $89,314,547 2,476,145
2023-03-31 $133,328,047 3,491,177
2022-12-31 $341,710,160 6,005,451
2022-09-30 $222,946,169 5,638,497
2022-06-30 $245,110,580 5,570,695
2022-03-31 $212,206,383 5,321,123
2021-12-31 $221,405,626 5,506,233
2021-09-30 $216,797,752 5,329,345
2021-06-30 $256,640,152 5,651,622
2021-03-31 $230,201,088 5,521,734
2020-12-31 $227,755,685 5,332,608
2020-09-30 $111,576,915 4,245,697
2020-06-30 $98,721,951 3,682,281
2020-03-31 $66,165,995 3,677,932